Agios Pharmaceuticals Inc. (NASDAQ: AGIO) stock closed at 24.53 per share at the end of the most recent trading day (a -1.49% change compared to the prior day closing price) with a volume of 211.60K shares and market capitalization of 1.37B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 562 people. Agios Pharmaceuticals Inc. CEO is Jacqualyn A. Fouse.

The one-year performance of Agios Pharmaceuticals Inc. stock is -15.94%, while year-to-date (YTD) performance is -12.64%. AGIO stock has a five-year performance of -66.65%. Its 52-week range is between 21.07 and 32.33, which gives AGIO stock a 52-week price range ratio of 30.73%

Agios Pharmaceuticals Inc. currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 1.53, a price-to-sale (PS) ratio of 161.68, a price to cashflow ratio of 50.40, a PEG ratio of -0.29, a ROA of -29.20%, a ROC of -28.07% and a ROE of -32.53%. The company’s profit margin is -%, its EBITDA margin is -3 884.70%, and its revenue ttm is $9.93 Million , which makes it $0.18 revenue per share.

Of the last four earnings reports from Agios Pharmaceuticals Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-1.69 for the next earnings report. Agios Pharmaceuticals Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Agios Pharmaceuticals Inc. is Moderate Buy (1.88), with a target price of $35.25, which is +43.70% compared to the current price. The earnings rating for Agios Pharmaceuticals Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Agios Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Agios Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.53, ATR14 : 0.85, CCI20 : -148.11, Chaikin Money Flow : -0.12, MACD : -0.49, Money Flow Index : 16.91, ROC : -7.64, RSI : 35.26, STOCH (14,3) : 8.18, STOCH RSI : 0.08, UO : 32.35, Williams %R : -91.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Agios Pharmaceuticals Inc. in the last 12-months were: Ballal Rahul (Sold 0 shares of value $0 ), Burns James William (Option Exercise at a value of $0), Burns James William (Sold 1 707 shares of value $48 411 ), Cecilia Jones (Sold 0 shares of value $0 ), Cecilia Jones (Sold 1 597 shares of value $45 291 ), David P. Schenkein (Option Excercise at a value of $1 234 085), David P. Schenkein (Sold 136 363 shares of value $3 510 182 ), Foster-Cheek Kaye I (Option Exercise at a value of $0), Fouse Jacqualyn (Option Excercise at a value of $0), Fouse Jacqualyn (Sold 10 718 shares of value $303 962 ), FOUSE JACQUALYN A (Option Exercise at a value of $0), FOUSE JACQUALYN A (Sold 10 718 shares of value $303 962 ), Gheuens Sarah (Sold 0 shares of value $0 ), Gheuens Sarah (Option Exercise at a value of $0), Gheuens Sarah (Sold 1 707 shares of value $48 411 ), Goff Brian (Sold 0 shares of value $0 ), Goff Brian (Option Exercise at a value of $0), Goff Brian (Sold 11 449 shares of value $324 694 ), Ho Maykin (Option Excercise at a value of $0), Ho Maykin (Option Exercise at a value of $0), Jacqualyn A. Fouse (Option Excercise at a value of $0), James William Burns (Option Excercise at a value of $0), James William Burns (Sold 1 707 shares of value $48 411 ), Jones Cecilia (Option Exercise at a value of $0), Jones Cecilia (Sold 1 597 shares of value $45 291 ), Kaye I. Foster-Cheek (Option Excercise at a value of $0), Milanova Tsveta (Sold 0 shares of value $0 ), Milanova Tsveta (Option Exercise at a value of $0), Milanova Tsveta (Sold 1 618 shares of value $45 886 ), Richa Poddar (Option Excercise at a value of $0), Sarah Gheuens (Option Excercise at a value of $0), Scadden David (Option Exercise at a value of $0), Schenkein David (Option Excercise at a value of $1 234 085), Schenkein David (Sold 136 363 shares of value $3 510 182 ), Schenkein David P (Option Exercise at a value of $0), Smith Cynthia (Sold 0 shares of value $0 ), T. J. Washburn (Option Excercise at a value of $0), T. J. Washburn (Sold 1 241 shares of value $32 991 ), Theodore James. Washburn (Option Excercise at a value of $0), Theodore James. Washburn (Sold 5 391 shares of value $139 432 )